UBS analyst Graham Doyle upgraded GE HealthCare (NASDAQ: GEHC) from Sell to Neutral with a price target of $69.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Upgrades